StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) stock

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.00+0.09 (+3.09%)

Close on Nov 17, 2026Market cap $11.85MP/E –Yield –

Onconetix total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Onconetix's total debt was $118.45K at Sep 30, 2024. For fiscal 2023 it was $118.86K, down 74.3% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$118.86K-74.3%
FY2022Dec 31, 2022$462.52K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024$118.45K-74.4%
Q2 FY2024Jun 30, 2024$111.26K-75.9%
Q1 FY2024Mar 31, 2024$110.87K–
Q4 FY2023Dec 31, 2023$118.86K–
Q2 FY2023Jun 30, 2023$462.52K–
Q4 FY2022Dec 31, 2022$462.52K–

More Onconetix figures

See a number that looks wrong?